ETF comparison
FHLC vs IBB
Both Healthcare.
Fidelity MSCI Health Care Index ETF · iShares Biotechnology ETF
Holdings overlap
148 positions appear in both funds. Buying equal dollars of FHLC and IBB would leave roughly 17.6% of each dollar exposed to the same underlying securities.
Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.
Side by side
Sub-score comparison
Tracking quality isn't part of the composite — see what we don't score for why.
Cost difference
FHLC is 36 bps cheaper than IBB. On a $100,000 position that's about $356/yr more in fees for IBB.
Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs IBB.
Top shared holdings
148 shared in total| # | Holding | In FHLC | In IBB | Overlap |
|---|---|---|---|---|
| 1 | Amgen Inc | 3.00% | 7.83% | 3.00% |
| 2 | Gilead Sciences Inc | 2.34% | 6.84% | 2.34% |
| 3 | Vertex Pharmaceuticals Inc | 1.76% | 8.08% | 1.76% |
| 4 | Regeneron Pharmaceuticals Inc | 1.15% | 4.91% | 1.15% |
| 5 | Natera Inc | 0.52% | 2.89% | 0.52% |
| 6 | Illumina Inc | 0.44% | 2.07% | 0.44% |
| 7 | Revolution Medicines Inc | 0.44% | 2.78% | 0.44% |
| 8 | Biogen Inc | 0.43% | 2.47% | 0.43% |
| 9 | Alnylam Pharmaceuticals Inc | 0.39% | 3.12% | 0.39% |
| 10 | Insmed Inc | 0.30% | 1.78% | 0.30% |
| 11 | United Therapeutics Corp | 0.30% | 1.73% | 0.30% |
| 12 | Incyte Corp | 0.29% | 1.75% | 0.29% |
Only in FHLC
186 total- Eli Lilly & Co 13.35%
- Johnson & Johnson 8.93%
- AbbVie Inc 6.42%
- UnitedHealth Group Inc 5.44%
- Merck & Co Inc 4.66%
- Thermo Fisher Scientific Inc 3.09%
- Abbott Laboratories 2.66%
- Pfizer Inc 2.06%
- Bristol-Myers Squibb Co 1.93%
- CVS Health Corp 1.92%
Only in IBB
100 total- Argenx SE 3.76%
- BeOne Medicines Ltd. 1.77%
- Ascendis Pharma A/S 1.29%
- Genmab A/S 1.12%
- Abivax SA 0.67%
- BioNTech SE 0.66%
- Nuvalent, Inc. 0.50%
- Legend Biotech Corp. 0.33%
- Structure Therapeutics, Inc. 0.24%
- Caris Life Sciences, Inc. 0.17%
Related comparisons
More comparisons with FHLC
- FHLC vs IHF · iShares U.S. Healthcare Providers ETF 15.4%
- FHLC vs IHI · iShares U.S. Medical Devices ETF 14.2%
- FHLC vs XBI · State Street SPDR S&P Biotech ETF 12.6%
- FHLC vs VGT · Vanguard Information Technology Index Fund ETF Shares 0.0%
- FHLC vs XLK · State Street Technology Select Sector SPDR ETF 0.0%
- FHLC vs VHT · Vanguard Health Care Index Fund ETF Shares 95.2%
More comparisons with IBB
- IBB vs XLV · State Street Health Care Select Sector SPDR ETF 11.1%
- IBB vs IXJ · iShares Global Healthcare ETF 8.3%
- IBB vs IHF · iShares U.S. Healthcare Providers ETF 0.1%
- IBB vs IHI · iShares U.S. Medical Devices ETF 0.1%
- IBB vs VGT · Vanguard Information Technology Index Fund ETF Shares 0.0%
- IBB vs XLK · State Street Technology Select Sector SPDR ETF 0.0%
Percentages are holdings overlap with the named fund.
Open FHLC or IBB at a brokerage
Both funds trade commission-free at major US brokerages.
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.
Holdings overlap is the sum of min(weight_a, weight_b) over positions
matched on ISIN (CUSIP fallback). Methodology: see
/methodology/.
Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.